MedTrace Logo

Pertussis and Meningitis C Concomitant Vaccination in Adolescents

NCT02526394 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2019-03-22

No results posted yet for this study

Summary

The trial includes groups receiving various combinations of meningitis C and pertussis containing vaccines, to be administered concomitantly in adolescents due their school leaving booster vaccinations (as per UK routine immunisation schedule at 13-17 years of age). Immunogenicity and reactogenicity will be assessed.

Conditions

  • Pertussis
  • Meningitis
  • Preventive Immunization; Meningitis
  • Immunization

Interventions

BIOLOGICAL

Meningococcal vaccine

Meningococcal vaccination

DRUG

Pertussis containing vaccine

Pertussis containing vaccination

Sponsors & Collaborators

  • Public Health England

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United Kingdom

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02526394 on ClinicalTrials.gov